Navigation Links
Cepheid Reports Second Quarter Revenue of $42.1 Million
Date:7/24/2008

entions, beliefs, expectations and strategies for the future, including those relating to potential growth in clinical product sales, future revenues and gross margin and demand for certain products, future net income and other future operating results. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the Company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: our success in increasing direct sales and the effectiveness of new sales personnel; the performance and market acceptance of new products; sufficient customer demand; our ability to develop and complete clinical trials successfully in a timely manner for new products; uncertainties related to the FDA regulatory and European regulatory processes; the level of testing at clinical customer sites; changes in the protocols or level of testing for MRSA and other HAIs; the mix of products sold, which can affect gross margins; the rate of environmental biothreat testing conducted by the USPS, which will affect the amount of consumable products sold to the USPS; unforeseen development and manufacturing problems; the potential need for additional licenses for new tests and other products and the terms of such licenses; lengthy sales cycles in certain markets; the Company's ability to continue to realize manufacturing efficiencies, which are an important factor in improving gross margins; the Company's reliance on distributors in some regions to market, sell and support its products; the occurrence of unforeseen expenditures, acquisitions or other transactions; the impact of acquisitions; the impact of competitive products and pricing; the Company's ability to manage geographically-dispersed operations; and underlying market conditions worldwide. Readers should also refer to the section entitled "Risk Factors" in Cepheid's Ann
'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... A challenge donation from the Bezos family ... total to more than $7 million for Fred Hutchinson ... of the live auction during which guests raise their ... million to be directed toward the Hutchinson Center,s work ... ,, The black-tie Gala took place Dec. 5 ...
(Date:12/6/2009)... Boehringer Ingelheim today announced results from ... BID), a direct thrombin inhibitor (DTI),(2) compared to ... Results of the trial were presented at the ... simultaneously published online in the New England ... met the primary outcome of the trial, six ...
(Date:12/4/2009)... of Standards and Technology (NIST) and the Naval Research ... impurities in a semiconductor crystal by prodding it with ... paper,* this technique will enable researchers to selectively implant ... learn about its electrical and magnetic properties on the ...
(Date:12/4/2009)... CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin ... on December 1, 2009 will receive the dividend of ... previously approved by Vivakor,s Board of Directors. HealthAmerica ... approximately 84% of the outstanding common shares on the ...
Breaking Biology Technology:34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 234th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3
... Development Programs; Agreement Underscores SAFC,s Commitment to Japan ... SAFC Hitech (R), a business segment ... SIAL ), today underlined its commitment to Japan,s microelectronics ... leading industrial and medical gas producer, Air Water ...
... MesenCult®-ACF Medium , the first defined, animal component-free (ACF) ... (MSCs). , ... Vancouver, B.C. ... the release of MesenCult®-ACF Medium, the first defined, animal component-free ...
... Monash University scientists have unlocked the physics of the ... the next generation of micro motors thinner that a ... student supervised by Associate Professor James Friend and Senior ... work. The team from Monash,s Micro/Nanophysics Research Laboratory, then ...
Other Biology Technology:SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 2SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 3SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 4SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 5STEMCELL Technologies Introduces a New Animal Component-Free, Serum-Free Medium for Culturing Human Mesenchymal Stem Cells 2Pizza tossing art unlocks secrets of tiny motors 2
(Date:12/6/2009)... Dec. 7, 2009, New York, N.Y./Los Angeles, Calif.: ... is awarding $9.68 million to support high-risk/high-reward cancer research ... each investigator will receive a total of up to ... which supports the next generation of cancer research leaders. ... to step outside their comfort zones and strive to ...
(Date:12/6/2009)... Just three months after the Euro 5 Norm for ... models, researchers at the Technische Universitaet Muenchen (TUM) have ... the more stringent Euro 6 emissions standard. A research ... of Internal Combustion Engines has succeeded in reducing the ... TUM engineers have also developed a probe that allows ...
(Date:12/5/2009)... The oceans could become the source of more of ... improve marine aquaculture, according to a study published in ... As the world,s population continues to grow, lack of ... unlikely to be able to meet food demand, according ... Balearic Islands, Spain, and his seven coauthors. Freshwater aquaculture, ...
Breaking Biology News(10 mins):Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3Clemson bioengineer uses nanoparticles to target drugs 10293 1Clemson bioengineer uses nanoparticles to target drugs 10293 2American Podiatric Medical Association Grants Seal of Acceptance for Work Footwear 59132 1American Podiatric Medical Association Grants Seal of Acceptance for Work Footwear 59132 2American Podiatric Medical Association Grants Seal of Acceptance for Work Footwear 59132 3Health Care Varies From State to State 59130 1Health Care Varies From State to State 59130 2
... by producing significant amounts of a chemical form of ... the National Center for Atmospheric Research (NCAR), opens up ... and their impacts on air quality, and it also ... signal about crops that are failing. , "Unlike humans, ...
... has long been thought that virus infections can cause ... Lisewski, Dr. Yu Shi, Michael Radke and Professor Michael ... (MDC) Berlin-Buch, Germany, have now discovered the molecular mechanism. ... uses to infect heart cells is normally necessary for ...
... for Anyone with Access to,the Cockpit, ... a,Southwest Airlines pilot will be the first ... Security Administration (TSA) using an advanced,biometric screening ... utilize biometrics to positively identify aircrew,members, making ...
Other Biology News:Plants in forest emit aspirin chemical to deal with stress; discovery may help agriculture 2Plants in forest emit aspirin chemical to deal with stress; discovery may help agriculture 3New mechanism for cardiac arrhythmia discovered 2Southwest Pilots Launch TSA Demonstration Project to Test Biometric Screening 2
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
... For use with suspension ... RiboCap™ uses vacuum filtration or ... culture media. Compatible with ... available in larger package sizes ...
GOAT ANTI SLI...
...
Biology Products: